Related references
Note: Only part of the references are listed.Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Filipe Martins et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management
Uday N. Shivaj et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)
A comprehensive review of the role of immune checkpoint inhibitors in brain metastasis of renal cell carcinoma origin
Joseph Kattan et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Rasch analysis of the Herth Hope Index in cancer patients
Tone Rustoen et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2018)
CNS side effects of immune checkpoint inhibitors: preclinical models, genetics and multimodality therapy
Gwendolyn J. McGinnis et al.
IMMUNOTHERAPY (2017)
Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients
Guillermo De Velasco et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Psychological side effects of immune therapies: symptoms and pathomechanism
David Kovacs et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Jeffrey S. Weber et al.
LANCET ONCOLOGY (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Cytokines and Chemokines at the Crossroads of Neuroinflammation, Neurodegeneration, and Neuropathic Pain
Geeta Ramesh et al.
MEDIATORS OF INFLAMMATION (2013)
The Brief Psychiatric Rating Scale (version 4.0) factorial structure and its sensitivity in the treatment of outpatients with unipolar depression
Adriano Zanello et al.
PSYCHIATRY RESEARCH (2013)
Cancer- and Cancer Treatment-Associated Cognitive Change: An Update on the State of the Science
Tim A. Ahles et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Immune system to brain signaling: Neuropsychopharmacological implications
Lucile Capuron et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Inflammatory Biomarkers and Fatigue during Radiation Therapy for Breast and Prostate Cancer
Jullienne E. Bower et al.
CLINICAL CANCER RESEARCH (2009)
Is perceived nervousness and anxiety a predictor of premature mortality and severe morbidity?: A longitudinal follow up of the Swedish survey of living conditions
GR Weitoft et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2005)
Immunological aetiology of major psychiatric disorders - Evidence and therapeutic implications
B Sperner-Unterweger
DRUGS (2005)
The Swedish version of Herth Hope Index - an instrument for palliative care
E Benzein et al.
SCANDINAVIAN JOURNAL OF CARING SCIENCES (2003)
Immunotherapy: past, present and future
TA Waldmann
NATURE MEDICINE (2003)
Share Paper
